Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab

J Allergy Clin Immunol. 2007 Oct;120(4):979-81. doi: 10.1016/j.jaci.2007.07.041.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angioedema / drug therapy*
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Male
  • Middle Aged
  • Omalizumab
  • Recurrence

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab